Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H12N6 |
InChIKeyGONXJTJRZCPBLD-UHFFFAOYSA-N |
CAS Registry226081-74-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Attention Deficit Disorder With Hyperactivity | Phase 2 | US | 01 Jun 2013 | |
Vasomotor symptom | Preclinical | US | 01 Jan 2014 |